Smith Stella R, Morris Louise, Spreadborough Stephen, Al-Obaydi Waleed, D'Auria Marta, White Hilary, Brooks Adam J
University Hospital South Manchester, Southmoor Road, Wythenshawe, M23 9LT, Manchester, UK.
East Midlands Major Trauma Centre, Queens Medical Centre, Nottingham, UK.
Eur J Trauma Emerg Surg. 2018 Jun;44(3):397-406. doi: 10.1007/s00068-017-0807-5. Epub 2017 Jun 9.
To review the management of patients >16 years with blunt splenic injury in a single, UK, major trauma centre and identify whether the following are associated with success or failure of non-operative management with selective use of arterial embolization (NOM ± AE): age, Injury Severity Score (ISS), head injury, haemodynamic instability, massive transfusion, radiological hard signs [contrast extravasation or pseudoaneurysm on the initial computed tomography (CT) scan], grade, and presence of intraparenchymal haematoma or splenic laceration.
Retrospective, cross-sectional study undertaken between April 2012 and October 2015. Paediatric patients, penetrating splenic trauma, and iatrogenic injuries were excluded. Follow-up was for at least 30 days.
154 patients were included. Median age was 38 years, 77.3% were male, and median ISS was 22. 14/87 (16.1%) patients re-bled following NOM in a median of 2.3 days (IQR 0.8-3.6 days). 8/28 (28.6%) patients re-bled following AE in a median of 2.0 days (IQR 1.3-3.7 days). Grade III-V injuries are a significant predictor of the failure of NOM ± AE (OR 15.6, 95% CI 3.1-78.9, p = 0.001). No grade I injuries and only 3.3% grade II injuries re-bled following NOM ± AE. Age ≥55 years, ISS, radiological hard signs, and haemodynamic instability are not significant predictors of the failure of NOM ± AE, but an intraparenchymal or subcapsular haematoma increases the likelihood of failure 11-fold (OR 10.9, 95% CI 2.2-55.1, p = 0.004).
Higher grade injuries (III-V) and intraparenchymal or subcapsular haematomas are associated with a higher failure rate of NOM ± AE and should be managed more aggressively. Grade I and II injuries can be discharged after 24 h with appropriate advice.
回顾英国一家主要创伤中心对16岁以上钝性脾损伤患者的治疗情况,并确定以下因素是否与选择性使用动脉栓塞术(NOM±AE)的非手术治疗的成功或失败相关:年龄、损伤严重度评分(ISS)、头部损伤、血流动力学不稳定、大量输血、放射学硬指标(初次计算机断层扫描(CT)上的对比剂外渗或假性动脉瘤)、分级以及实质内血肿或脾撕裂伤的存在情况。
2012年4月至2015年10月进行的回顾性横断面研究。排除儿科患者、穿透性脾外伤和医源性损伤。随访至少30天。
纳入154例患者。中位年龄为38岁,77.3%为男性,中位ISS为22。14/87(16.1%)例患者在非手术治疗后再次出血,中位时间为2.3天(四分位间距0.8 - 3.6天)。8/28(28.6%)例患者在动脉栓塞术后再次出血,中位时间为2.0天(四分位间距1.3 - 3.7天)。III - V级损伤是NOM±AE治疗失败的显著预测因素(比值比15.6,95%置信区间3.1 - 78.9,p = 0.001)。在NOM±AE治疗后,I级损伤无再次出血情况,II级损伤仅有3.3%再次出血。年龄≥55岁、ISS、放射学硬指标和血流动力学不稳定不是NOM±AE治疗失败的显著预测因素,但实质内或包膜下血肿使失败可能性增加11倍(比值比10.9,95%置信区间2.2 - 55.1,p = 0.004)。
较高级别的损伤(III - V级)以及实质内或包膜下血肿与NOM±AE的较高失败率相关,应采取更积极的治疗措施。I级和II级损伤在给予适当建议后24小时即可出院。